... appears to have a good predictive performance for the occurrence of PS-AKI. Interventional trials to study a biomarker-guided application of AKI care bundles and RRT are indicated. [email protected] 1 02 2024 16 08 2024 24 08 2024 © 2024 S. Karger AG, Basel Copyright...

... constituents of the extracellular matrix and play a crucial role in the progression of EPS. As a new biomarker, MMP-2 may improve the detection rate of EPS patients in clinical work. In this review, we summarize the recent study of MMP-2 in different etiologies and the assessment of its application value...

... (cTNFR) levels as prognostic biomarkers in severe acute kidney injury (AKI) patients requiring continuous renal replacement therapy (CRRT). Methods: We enrolled 136 patients from 7 hospitals participating in the VENUS (VolumE maNagement Under body composition monitoring in critically ill patientS on CRRT...

... from any ideas, methods, instructions or products referred to in the content or advertisements. 2022 Uremic toxins Chronic kidney disease End-stage kidney disease Dialyzer types Artificial intelligence Biomarkers In its literal sense, uremia conveys the accumulation of urea...

..., instructions or products referred to in the content or advertisements. Peritoneal dialysis Hemodialysis Technique failure Biomarkers Hemodialysis Meta-Analysis Blood Purif 2021;50:42 49 DOI: 10.1159/000508159 Received: December 9, 2019 Accepted: April 23, 2020 Published online: July 17, 2020...

...Marco Fiorentino; Fadi A. Tohme; Raghavan Murugan; John A. Kellum Background: Numerous studies have suggested a possible role for acute kidney injury (AKI) biomarkers in predicting renal recovery both before and after renal replacement therapy (RRT). However, definitions for recovery and whether...

... results. High- and moderate-risk patients with a positive biomarker (such as urinary tissue inhibitor of metalloproteinases-2 (TIMP-2)*insulin-like growth factor-binding protein 7 (IGFBP7) should activate NRRT consultation. CKD stage 3 and higher patients are automatically considered at high risk...

... in the progression of AKI and transitions from AKI to CKD and ESRD. Although promising advances have been made in understanding the pathophysiology of AKI and AKI consequences, much more work needs to be done in developing biomarkers for detecting early kidney injury, prognosticating kidney disease progression...

... the complexities of organ cross-talk, enabling effective therapies. We discuss the available data on the commonly studied biomarkers of acute kidney injury with reference to the cardiorenal syndrome. Furthermore, we propose how the use of biomarkers as a panel may provide information which can guide therapy...

...John W. Pickering; Zoltan H. Endre Background and Aim: Neutrophil gelatinase-associated lipocalin (NGAL) is derived from the distal tubule and is both reabsorbed and filtered and also shed into the urine after tubular injury. Plasma NGAL is unique amongst the candidate biomarkers of acute kidney...

... of AKI. In a septic state, sNGAL alone did not discriminate patients with AKI from those without AKI. 28 08 2012 11 12 2012 15 2 2013 Median levels of measured biomarkers did not significantly change during the 3 study days in our cohort of septic patients (p = 0.05) (fig. 1...

... Cardiosurgery, Bambino Gesù Hospital, Rome, and bDepartment of Nephrology, Dialysis and Transplantation, S. Bortolo Hospital, Vicenza, Italy Key Words Acute kidney injury RIFLE classification Biomarkers Fenoldopam Renal replacement therapy Abstract The present review describes recent evidence on all...

...Maurizio Bossola; Luigi Tazza; Esther Merki; Stefania Giungi; Giovanna Luciani; Elizabeth R. Miller; Edward B. Lin; Antonio Tortorelli; Sotirios Tsimikas Objective: To assess the effect of end-stage renal failure on oxidized low-density lipoprotein (OxLDL) biomarkers and the acute effects...